Prostate-specific antigen doubling time among Japanese men in an annual health screening program
Open Access
- 12 October 2004
- journal article
- Published by Wiley in International Journal of Urology
- Vol. 11 (10), 856-861
- https://doi.org/10.1111/j.1442-2042.2004.00904.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Feasibility Study: Watchful Waiting For Localized Low To Intermediate Grade Prostate Carcinoma With Selective Delayed Intervention Based On Prostate Specific Antigen, Histological And/Or Clinical ProgressionJournal of Urology, 2002
- THE INCIDENCE OF PROSTATE CANCER IN A SCREENING POPULATION WITH A SERUM PROSTATE SPECIFIC ANTIGEN BETWEEN 2.5 AND 4.0 NG./ML.: RELATION TO BIOPSY STRATEGYJournal of Urology, 2001
- Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomyProstate Cancer and Prostatic Diseases, 2000
- PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGENJournal of Urology, 2000
- EVALUATION OF CHANGES IN PROSTATE SPECIFIC ANTIGEN IN CLINICALLY LOCALIZED PROSTATE CANCER MANAGED WITHOUT INITIAL THERAPYJournal of Urology, 1998
- CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGENJournal of Urology, 1998
- Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a ‘rapid riser’ subsetBritish Journal of Urology, 1998
- Histological Characteristics of Radical Prostatectomy Specimens in Men with a Serum Prostate Specific Antigen of 4 ng./ml. or LessJournal of Urology, 1996
- Prostate-Specific Antigen as Predictor of Prostate Cancer in Black Men and White MenJNCI Journal of the National Cancer Institute, 1995
- Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volumeCancer, 1993